Elevated STAT1 expression correlates with prolonged cancer-specific survival in patients with localized PCa, while no STAT1 expression in patients with advanced PCa is accompanied by early biochemical recurrence [107]. This evidence concerns the gene STAT1 and posterior cortical atrophy.